
Zicfi SL 250mg/125mg Injection
Marketer
Biotic Healthcare
Salt Composition
Ceftriaxone (250mg) + Sulbactam (125mg)
Overview Zicfi SL 250mg/125mg Injection
Cefixime and Sulbactam 250mg/125mg injection is a dual-action antibiotic. It's used to combat diverse bacterial infections by inhibiting microbial growth and preventing infection spread. Administration should always be under a doctor's guidance. Complete the prescribed treatment regimen; premature cessation can reduce its effectiveness. Common side effects include nausea, vomiting, diarrhea, and upset stomach. Report worsening side effects immediately. Seek urgent medical attention for allergic reactions like rash, itching, swelling, or breathing difficulties. Inform your physician of all other medications before use. Pregnant or nursing individuals require medical consultation prior to use. Alcohol should be avoided due to potential increased drowsiness. While it typically doesn't impair driving, refrain from driving if feeling drowsy or dizzy. Adequate rest, a balanced diet, and ample hydration aid recovery. Your doctor might order tests to monitor the medication's effects.
Uses of Zicfi SL 250mg/125mg Injection
Infections caused by bacteria
Major Benefits of Zicfi SL 250mg/125mg Injection:
This medication will be administered by your healthcare provider. Self-medication is not advised.
Common Side effects of Zicfi SL 250mg/125mg Injection:
- Increased white blood cell count (eosinophils)
- Decreased white blood cell count (lymphocytes)
- Low blood platelets
- Rash
- Diarrhea
- Increased liver enzymes
- Injection site reactions (pain, swelling, redness)
How to use Zicfi SL 250mg/125mg Injection:
This medication will be administered by your healthcare provider. Self-medication is strictly prohibited.
How Zicfi SL 250mg/125mg Injection works:
Zicfi SL Injection, containing 250mg Ceftriaxone and 125mg Sulbactam, utilizes a dual-antibiotic approach. Ceftriaxone, a broad-spectrum antibiotic, disrupts bacterial cell wall synthesis, hindering their growth and survival. Sulbactam, a beta-lactamase inhibitor, counteracts bacterial resistance mechanisms, thereby boosting Ceftriaxone's effectiveness.
SAFETY ADVICE
AlcoholSAFE
Zicfi SL 250mg/125mg Injection's concurrent use with alcohol poses no known adverse reactions.
PregnancySAFE IF PRESCRIBED
The injectable medication Zicfi SL 250mg/125mg is typically deemed safe for use during gestation. Preclinical trials in animals revealed minimal or absent negative impacts on fetal development; nevertheless, data from human trials are scarce.
Breast feedingCAUTION
Administering Zicfi SL 250mg/125mg Injection to breastfeeding mothers requires careful consideration. Lactation should be temporarily discontinued throughout the mother's treatment course and until the medication is fully cleared from her system.
DrivingUNSAFE
Administering Zicfi SL 250mg/125mg Injection can lead to reduced awareness, visual impairment, drowsiness, and dizziness. Driving is prohibited should these effects manifest.
KidneyCONSULT YOUR DOCTOR
Insufficient data exists regarding the administration of Zicfi SL 250mg/125mg Injection to individuals with renal impairment. Seek medical advice.
LiverCAUTION
Patients with severe hepatic impairment should use Zicfi SL 250mg/125mg Injection cautiously, potentially requiring dosage modification. Consult a physician for guidance. Dosage alteration for Zicfi SL 250mg/125mg Injection is unnecessary in individuals with mild or moderate liver dysfunction.
What if you forget to take Zicfi SL 250mg/125mg Injection :
Should you forget a scheduled dose of Zicfi SL 250mg/125mg Injection, seek immediate medical advice.
Facts to Know About Zicfi SL 250mg/125mg Injection
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Antimicrobial Agents |
